Trial intelligence / Profile preview

FP-10 for Helicobacter Pylori Eradication

NCT00281047Phase 3Unknown

Sponsor
Hamamatsu University School of Medicine
Start
Jan 2006
Modality
Nutraceutical
Countries
1
01

Overview

A Phase 3 trial of FP-10 in Helicobacter pylori infection, sponsored by Hamamatsu University School of Medicine. Status: unknown.

02

Drugs

FP-10
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT00281047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00281047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call